Forget the "Magnificent Seven": Buy This Stock Instead
In this article:
With the Nasdaq Composite up by 36% this year, those equities known as the "Magnificent Seven" have done quite a bit of the work. The company in question is biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX).